Equities research analysts at Loop Capital began coverage on shares of Astera Labs (NASDAQ:ALAB – Get Free Report) in a research report issued on Thursday, MarketBeat.com reports. The brokerage set a “buy” rating and a $250.00 price target on the stock. Loop Capital’s price objective points to a potential upside of 109.73% from the company’s previous close.
Other analysts also recently issued reports about the stock. Barclays set a $165.00 price objective on shares of Astera Labs in a report on Thursday, January 15th. Needham & Company LLC lifted their target price on shares of Astera Labs from $205.00 to $220.00 and gave the stock a “buy” rating in a report on Wednesday, November 5th. JPMorgan Chase & Co. boosted their target price on shares of Astera Labs from $180.00 to $215.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 5th. Citigroup decreased their price target on shares of Astera Labs from $275.00 to $250.00 and set a “buy” rating for the company in a report on Wednesday, February 11th. Finally, Weiss Ratings lowered Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, February 23rd. Fifteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Astera Labs presently has a consensus rating of “Moderate Buy” and a consensus target price of $195.89.
View Our Latest Research Report on ALAB
Astera Labs Stock Performance
Astera Labs (NASDAQ:ALAB – Get Free Report) last announced its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.51 by $0.07. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The firm had revenue of $270.58 million during the quarter, compared to analysts’ expectations of $249.46 million. During the same quarter in the prior year, the business earned $0.37 earnings per share. The company’s revenue was up 91.8% on a year-over-year basis. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, analysts anticipate that Astera Labs will post 0.34 earnings per share for the current fiscal year.
Insider Activity at Astera Labs
In related news, COO Sanjay Gajendra sold 94,971 shares of the company’s stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the completion of the transaction, the chief operating officer directly owned 1,531,301 shares in the company, valued at $189,590,376.81. This represents a 5.84% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Michael Truett Tate sold 12,001 shares of the company’s stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total transaction of $1,485,843.81. Following the transaction, the chief financial officer owned 192,083 shares of the company’s stock, valued at approximately $23,781,796.23. The trade was a 5.88% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 216,792 shares of company stock worth $26,777,569. 12.50% of the stock is owned by insiders.
Institutional Inflows and Outflows
A number of large investors have recently made changes to their positions in ALAB. Vanguard Group Inc. boosted its holdings in Astera Labs by 29.6% during the second quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company’s stock valued at $1,089,491,000 after purchasing an additional 2,751,747 shares in the last quarter. Atreides Management LP grew its stake in shares of Astera Labs by 2,496.6% in the 4th quarter. Atreides Management LP now owns 1,611,194 shares of the company’s stock valued at $268,038,000 after purchasing an additional 1,549,144 shares during the period. Amundi raised its holdings in shares of Astera Labs by 1,298.6% in the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock worth $278,283,000 after buying an additional 1,319,643 shares in the last quarter. Rafferty Asset Management LLC bought a new position in shares of Astera Labs during the 3rd quarter worth approximately $209,599,000. Finally, BNP Paribas Financial Markets lifted its position in shares of Astera Labs by 577.3% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock worth $220,733,000 after buying an additional 960,899 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.
Astera Labs News Summary
Here are the key news stories impacting Astera Labs this week:
- Positive Sentiment: Loop Capital initiated coverage with a Buy and a $250 price target, highlighting Astera’s role in AI datacenter connectivity and providing a sizable upside thesis for the stock. Read More.
- Positive Sentiment: An initiation piece argues Astera can still be an “AI winner,” reinforcing investor interest in its connectivity chips and software for high‑bandwidth servers. Read More.
- Positive Sentiment: Recent quarterly results showed a revenue and EPS beat and management set modest Q1 EPS guidance, supporting the growth story behind multiple analyst Buy ratings. Read More.
- Neutral Sentiment: Analysts and outlets flag that ALAB is trading at a premium valuation and faces stiff competition — that supports a cautious stance despite strong end‑market demand. Read More.
- Neutral Sentiment: Coverage pieces note mixed share‑price signals vs growth expectations, leaving valuation and timing as the primary debate among investors. Read More.
- Neutral Sentiment: Several writeups describe a shifting investment narrative as analysts update models — positive for long‑term thesis but creating short‑term opinion dispersion. Read More.
- Negative Sentiment: Coverage reports that a margin “reset” tied to an Amazon AI deal could compress near‑term margins, raising execution and profitability concerns for investors focused on margin expansion. Read More.
- Negative Sentiment: Insider selling: Astera’s General Counsel sold 10,000 shares (disclosed early March), which some investors interpret as a near‑term negative signal even though insiders still hold large stakes. Read More.
Astera Labs Company Profile
Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.
The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.
Featured Articles
- Five stocks we like better than Astera Labs
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Unlocked: Elon Musk’s Next Big IPO
- Elon Musk already made me a “wealthy man”
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
